𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Doxifluridine (5′-dFUrd) in patients with advanced colorectal carcinoma

✍ Scribed by Sophie D. Fosså; Olav Dahl; Roar Hoel; Mona Heier; Mitchell Loeb

Publisher
Springer
Year
1985
Tongue
English
Weight
266 KB
Volume
15
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of spirogermanium in pati
Phase II study of spirogermanium in patients with advanced colorectal carcinoma
✍ Jaffer A. Ajani; Jack S. Faintuch; Roxann K. McClure; Bernard Levin; Bruce M. Bo 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 193 KB

Twenty one evaluable patients with advanced colorectal carcinoma were treated with continuous infusion of spirogermanium at a median daily dose of 150 mg/rn 2 (range 120-210) for five consecutive days every 14 days. Treatments were accomplished by using outpatient infusion devices. Fifteen patients

Oral doxifluridine plus levoleucovorin i
Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer
✍ Emilio Bajetta; Laura Biganzoli; Carlo Carnaghi; Maria Di Bartolomeo; Ivo Spagno 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## BACKGROUND. There currently is no agreement regarding the appropriate treatment of elderly patients with advanced breast carcinoma (ABC). Doxifluridine (5-dFUR), a prodrug of 5-fluorouracil, has been found to be effective in this entity, but its use is limited by neurotoxicity and cardiotoxici

Rationale for bladder-sparing surgery in
Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinoma
✍ M. Derya Balbay; Joel W. Slaton; Nicholas Trane; John Skibber; Colin P. N. Dinne 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## BACKGROUND. Total pelvic exenteration (TPE) with urinary diversion is a standard surgical approach for patients with locally advanced rectal carcinoma. Because only approximately 50% of patients undergoing TPE have tumor involving the bladder, the authors evaluated the feasibility of bladder sa

Hypocalcemia associated with 5-fluoroura
Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas
✍ Yuichiro Kido; Takeshi Okamura; Morimasa Tomikawa; Manabu Yamamoto; Morio Shirai 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

## BACKGROUND. The biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (Lv) has demonstrated significantly increased response rates in comparison with the use of 5-FU alone in patients with advanced colorectal carcinoma. However, the higher response rate of LV/5-FU may occur at the expen